| Sophia Currie, | |
|
151 Capitol St Ste 4, Augusta, ME 04330-6262 | |
| (207) 512-8549 | |
| Not Available |
| Full Name | Sophia Currie |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 151 Capitol St Ste 4, Augusta, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841910676 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN76678 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sophia Currie, 151 Capitol St Ste 4, Augusta, ME 04330-6262 Ph: () - | Sophia Currie, 151 Capitol St Ste 4, Augusta, ME 04330-6262 Ph: (207) 512-8549 |
News Archive
An original and progressive report on health information technology (HIT) vendors, their customers and patients, published online today, makes ground-breaking recommendations for new practices that target the reduction or elimination of tensions that currently mar relationships between many HIT vendors and their customers, specifically with regard to indemnity and error management of HIT systems.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that the European Medicines Agency Committee for Orphan Medicinal Products has granted orphan medicinal product designation to ATX-F8-117 for the treatment of haemophilia A.
Premature births are intimately linked with inflammation of the uterine tissue, a biological response which induces contractions and preterm labor. In their search for a mean to prevent this phenomenon and complications related to deliveries occurring before 37 weeks of gestation, researchers at CHU Sainte-Justine and University of Montreal discovered an agent that shows efficacy in inhibiting inflammation and preventing or delaying uterine contractions and premature delivery in murine models - without adversely affecting the fetus or the mother.
Physio-Control, Inc., a wholly owned subsidiary of Medtronic, Inc., has announced it has received clearance from the U.S. Food and Drug Administration (FDA) to market the LIFEPAK 15 monitor/defibrillator within the United States.
› Verified 2 days ago
Ms. Beverly Ann Hayward, RN-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 66 Stone St, Augusta, ME 04330 Phone: 207-626-3455 | |
Ruby Baby, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 151 Capitol St Ste 4, Augusta, ME 04330 Phone: 207-512-8549 | |
Lisa Cloutier, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 151 Capitol St Ste 4, Augusta, ME 04330 Phone: 207-512-8549 | |
Elizabeth Chesnut, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-7400 Fax: 207-626-7401 | |
Nancy Hankins, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 151 Capitol St Ste 4, Augusta, ME 04330 Phone: 207-512-8549 | |
Gregory Stradtman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 151 Capitol St Ste 4, Augusta, ME 04330 Phone: 207-512-8549 | |
Mrs. Lisa Marie Tyler, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Mdp 171hb, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-623-5771 |